1Y Target$25.75Near-term target
5Y Target$36.06Compound horizon
10Y Target$53.01Long-dated conviction
FCF—TTM—FCF not applicable for this sector (bank / insurer / REIT) or data unavailable
Rev-4.2%TTM YoYD+Revenue -4.2% — shrinking; needs a catalyst to reverse · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E1.47C+D/E 1.47 — moderately levered, watch interest coverage
P/E73.1xD+P/E 73.1 — expensive; prices in flawless execution
PEG—proxy—PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Real Estate · market cap $1.4b. Trading near 52-week high of $22.80 — momentum setup, limited technical margin of safety.
Moat
Moat signals from the quantitative card are modest — profitability and capital efficiency are middle-of-pack. The thesis here depends on softer factors (switching costs, brand, distribution, regulatory protection) not captured by the 7-grade screen.
Risk
Trailing P/E 73.1x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Trading within 2% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. Net margin 4.4% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
Horizon
1-3 yr $25.75 (structural (no analyst coverage)) — fundamentals + valuation re-rating. 5 yr $36.06 at ~10% CAGR — compounding case rests on the competitive position widening. 10 yr $53.01 if current growth sustains into durable earnings power.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.